Last reviewed · How we verify

NCT07231484

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

Recruiting now NA Last updated 30 December 2025
What this trial tests

NA trial testing Freeze-dried grape powder in Obesity &Amp; Overweight in 50 participants. Currently enrolling.

Timeline
19 December 2025
Primary endpoint
20 December 2027
30 December 2027

Quick facts

Lead sponsorUniversity of Missouri-Columbia
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment50
Start date19 December 2025
Primary completion20 December 2027
Estimated completion30 December 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Missouri-Columbia

Who can join

Adults 30 to 45, any sex, with Obesity &Amp; Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obesity &Amp; Overweight

Currently open trials in the same condition.

Other University of Missouri-Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07231484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing